ArticleAnnals of hematology2026

PRDM16 expression is an independent prognostic factor in AML with the double-mutant NPM1/FLT3-ITD genotype.

Sebastian Stasik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.